Biologics Safety Testing Market: Leading Companies – Exclusive Report by MarketsandMarkets™

Global biologics safety testing market is projected to reach USD 6.2 billion by 2026 from USD 3.4 billion in 2021, at a CAGR of 12.4% during the forecast period. The growth of the global biologics safety testing market is driven by factors such as the growth in the biologics and biosimilars markets, growing concerns over cell culture contamination, and rising biopharmaceuticals R&D activities and investments.

Browse in-depth TOC on “Biologics Safety
Testing Market”

142 – Tables

42 – Figures

185 – Pages

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=34624144

Key Market Players

Prominent players in the biologics safety testing market are
Charles River Laboratories, Inc. (US), Lonza (Switzerland), Thermo Fisher
Scientific, Inc. (US), Merck KGaA (Germany), SGS SA (Switzerland), WuXi AppTec
(China), and Eurofins Scientific (Luxembourg).

Growth Strategies Adopted:

This market research study involved the extensive use of
secondary sources, directories, and databases to identify and collect
information useful for this technical, market-oriented, and financial study of
the global biologics safety testing market. The key players in this market are
focusing on strategic expansions, partnerships, and product launches and
approvals to expand their presence in the market.

CHARLES RIVER LABRATORIES (US)

Charles River is one of the key players in the biologics
safety testing market, it is a service and early-stage contract research
organization (CRO). The company develops a diverse portfolio of discovery and
safety assessment services and provides a suite of products and services to
support its clients’ manufacturing activities.

LONZA (SWITZERLAND)

Lonza is a key player in the biologics safety testing
market. The company has a large number of manufacturing and R&D facilities
across the globe. With its wide geographic presence and high production
capacity, the company delivers quality products across the globe.

THERMO FISCHER SCIENTIFIC (US)

Thermo Fisher Scientific offers analytical instruments,
equipment, reagents, and consumables for research, discovery, analysis,
diagnostics, and manufacturing. The company operates through four principal
product segments—Life Sciences Solutions, Analytical Instruments, Specialty
Diagnostics, and Laboratory Products and Services.

Request Sample Pages @  https://www.marketsandmarkets.com/requestsampleNew.asp?id=34624144

By application, the monoclonal antibodies manufacturing
segment accounted for the largest market share the Biologics safety testing
market

Based on application, the biologics safety testing market is
segmented into monoclonal antibodies manufacturing, vaccines manufacturing,
blood and blood products manufacturing, cellular and gene therapy products
manufacturing, and other applications. the monoclonal antibodies manufacturing
segment accounted for the largest market share. The large share of this segment
can be attributed to the rising prevalence of diseases and increasing
government initiatives for the development of monoclonal antibody drugs.

North America accounted for the largest share of the
Biologics safety testing market

North America accounted for the largest share of the
biologics safety testing market . Rapid growth in the biopharmaceutical
industry is the major factor driving the growth of the North American biologics
safety testing market. Speak to Analyst @  https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=34624144